Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 4
2002 1
2004 1
2005 2
2006 1
2007 4
2008 2
2009 1
2010 2
2011 1
2012 1
2014 1
2015 1
2017 1
2018 1
2019 1
2020 1
2021 1
2022 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean low dose erythromycin rokinetic (928 results)?
Management of acute upper gastrointestinal bleeding.
Stanley AJ, Laine L. Stanley AJ, et al. BMJ. 2019 Mar 25;364:l536. doi: 10.1136/bmj.l536. BMJ. 2019. PMID: 30910853
After resuscitation is initiated, proton pump inhibitors (PPIs) and the prokinetic agent erythromycin may be administered, with antibiotics and vasoactive drugs recommended in patients who have cirrhosis. ...Patients who require endoscopic therapy for ulcer bleeding …
After resuscitation is initiated, proton pump inhibitors (PPIs) and the prokinetic agent erythromycin may be administered, wit …
Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules.
Thevin P, Curti C, Benech A, Jean C, Lamy E, Castera Ducros C, Primas N, Bertault-Peres P, Vanelle P. Thevin P, et al. PLoS One. 2023 Feb 24;18(2):e0282164. doi: 10.1371/journal.pone.0282164. eCollection 2023. PLoS One. 2023. PMID: 36827282 Free PMC article.
OBJECTIVE: Erythromycin is a macrolide antibiotic that is also prescribed off-label in premature neonates as a prokinetic agent. There is no oral formulation with dosage and/or excipients adapted for these high-risk patients. METHODS: Clinical studies of erythrom …
OBJECTIVE: Erythromycin is a macrolide antibiotic that is also prescribed off-label in premature neonates as a prokinetic agen …
Optimal dose and duration of enteral erythromycin as a prokinetic: A surgical intensive care experience.
Shaikh N, Nainthramveetil MM, Nawaz S, Hassan J, Shible AA, Karic E, Singh R, Al Maslamani M. Shaikh N, et al. Qatar Med J. 2021 Jan 12;2020(3):36. doi: 10.5339/qmj.2020.36. eCollection 2020. Qatar Med J. 2021. PMID: 33447536 Free PMC article.
The mean duration of erythromycin therapy was 4.98 days. The most effective prokinetic dose of erythromycin was 125 mg twice daily (P = 0.001). ...Enteral erythromycin in combination with metoclopramide was effective in low dose an …
The mean duration of erythromycin therapy was 4.98 days. The most effective prokinetic dose of erythromycin was …
Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance.
Ng YY, Su PH, Chen JY, Quek YW, Hu JM, Lee IC, Lee HS, Chang HP. Ng YY, et al. Pediatr Neonatol. 2012 Feb;53(1):34-40. doi: 10.1016/j.pedneo.2011.11.007. Epub 2012 Jan 26. Pediatr Neonatol. 2012. PMID: 22348492 Free article. Clinical Trial.
The effectiveness and safety of intermediate-dose oral erythromycin in very low birth weight (VLBW) infants with feeding intolerance was examined in this study. ...No adverse effects were associated with erythromycin treatment. CONCLUSIONS: Intermediat …
The effectiveness and safety of intermediate-dose oral erythromycin in very low birth weight (VLBW) infants with feedin …
Erythromycin as a prokinetic agent in preterm neonates: a systematic review.
Patole S, Rao S, Doherty D. Patole S, et al. Arch Dis Child Fetal Neonatal Ed. 2005 Jul;90(4):F301-6. doi: 10.1136/adc.2004.065250. Epub 2005 May 17. Arch Dis Child Fetal Neonatal Ed. 2005. PMID: 15899929 Free PMC article.
Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results. ...No restrictions were applied on the dose (low: 3-12 mg/kg/day; antimicrobial: > or = 12 mg/kg/6-8 hours) and route (oral or intravenous) …
Clinical trials of erythromycin as a prokinetic agent in preterm neonates have reported conflicting results. ...No restriction …
Review article: erythromycin as a prokinetic agent in infants and children.
Curry JI, Lander TD, Stringer MD. Curry JI, et al. Aliment Pharmacol Ther. 2001 May;15(5):595-603. doi: 10.1046/j.1365-2036.2001.00964.x. Aliment Pharmacol Ther. 2001. PMID: 11328252 Review.
Animal and human studies have demonstrated a prokinetic effect on the gastrointestinal tract at sub-antimicrobial doses (typically a quarter or less of the antibiotic dose). ...The prokinetic effects of erythromycin have been investigated in infants wi …
Animal and human studies have demonstrated a prokinetic effect on the gastrointestinal tract at sub-antimicrobial doses (typically a …
QTc prolongation during erythromycin used as prokinetic agent in ICU patients.
Fiets RB, Bos JM, Donders A, Bruns M, Lamfers E, Schouten JA, Kramers C. Fiets RB, et al. Eur J Hosp Pharm. 2018 May;25(3):118-122. doi: 10.1136/ejhpharm-2016-001077. Epub 2017 Jan 18. Eur J Hosp Pharm. 2018. PMID: 31157004 Free PMC article.
BACKGROUND: High-dose erythromycin used as antibiotic prolongs QTc interval. Low-dose erythromycin is frequently used as a prokinetic agent, especially in patients in the intensive care unit (ICU). It is unknown whether low-dose …
BACKGROUND: High-dose erythromycin used as antibiotic prolongs QTc interval. Low-dose erythromycin is fre …
Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin.
Lightfoot AJ, Eno M, Kreder KJ, O'Donnell MA, Rao SS, Williams RD. Lightfoot AJ, et al. Urology. 2007 Apr;69(4):611-5. doi: 10.1016/j.urology.2006.12.027. Urology. 2007. PMID: 17445634 Clinical Trial.
OBJECTIVES: Treatment of postoperative ileus remains unsatisfactory. Erythromycin (EM), a macrolide antibiotic, has prokinetic effects on the gut. We investigated whether intravenous erythromycin decreases the time to the return of normal bowel function after …
OBJECTIVES: Treatment of postoperative ileus remains unsatisfactory. Erythromycin (EM), a macrolide antibiotic, has prokinetic …
High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
Ng PC, Lee CH, Wong SP, Lam HS, Liu FY, So KW, Lee CY, Fok TF. Ng PC, et al. Gastroenterology. 2007 May;132(5):1726-39. doi: 10.1053/j.gastro.2007.03.043. Epub 2007 Mar 24. Gastroenterology. 2007. PMID: 17484870 Free PMC article. Clinical Trial.
BACKGROUND & AIMS: Feeding intolerance because of functional gastrointestinal dysmotility and parenteral nutrition-associated cholestasis (PNAC) are common problems in preterm, very-low-birth-weight (VLBW) infants. This double-blind, randomized, placebo-controlled stud …
BACKGROUND & AIMS: Feeding intolerance because of functional gastrointestinal dysmotility and parenteral nutrition-associated cholestasi …
Use of prokinetics in the preterm infant.
Lam HS, Ng PC. Lam HS, et al. Curr Opin Pediatr. 2011 Apr;23(2):156-60. doi: 10.1097/MOP.0b013e3283431f2a. Curr Opin Pediatr. 2011. PMID: 21178622 Review.
Overall, neither low-dose regimes nor prophylactic trials have been shown to be useful. High-dose regimes used as rescue therapy of infants with established gastrointestinal dysmotility have consistently shown clinical benefit. Theoretical risks of prolonged …
Overall, neither low-dose regimes nor prophylactic trials have been shown to be useful. High-dose regimes used as rescu …
29 results